A brain proteomic signature of incipient Alzheimer’s disease in youngAPOEε4 carriers identifies novel drug targets
Author(s) -
Jackson A. Roberts,
Vijay R. Varma,
Yang An,
Sudhir Varma,
Julián Candia,
Giovanna Fantoni,
Vinod Tiwari,
Carlos Anerillas,
Andrew Williamson,
Atsushi Saito,
Tina Loeffler,
Irene Schilcher,
Ruin Moaddel,
Mohammed Khadeer,
Jacqueline Lovett,
Toshiko Tanaka,
Olga Pletniková,
Juan C. Troncoso,
David A. Bennett,
Marilyn S. Albert,
Kaiwen Yu,
Mingming Niu,
Vahram Haroutunian,
Bin Zhang,
Junmin Peng,
Deborah L. Croteau,
Susan M. Resnick,
Myriam Gorospe,
Vilhelm A. Bohr,
Luigi Ferrucci,
Madhav Thambisetty
Publication year - 2021
Publication title -
science advances
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.928
H-Index - 146
ISSN - 2375-2548
DOI - 10.1126/sciadv.abi8178
Subject(s) - apolipoprotein e , disease , drug , neuroscience , alzheimer's disease , drug target , medicine , biology , bioinformatics , pharmacology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom